A Study of EP0031 in Patients With Advanced RET-altered Malignancies

NCT05443126 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

265

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor
NSCLC

Interventions

DRUG: EP0031

Sponsor

Ellipses Pharma